{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:18:21Z","timestamp":1793744301036,"version":"4.6.1"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation (NRF) of Korea","award":["RS-2025-23963916"],"award-info":[{"award-number":["RS-2025-23963916"]}]},{"name":"Basic Science Research Program through the National Research Foundation (NRF) of Korea","award":["RS-2025-00517133, RS-2025-24792972"],"award-info":[{"award-number":["RS-2025-00517133, RS-2025-24792972"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06219-7","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:51:09Z","timestamp":1790142669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The SLC7A11 Thermostat: A Molecular Signaling Switch Between Ferroptosis and Disulfidptosis in Neurodegenerative Disease"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-0943","authenticated-orcid":false,"given":"Mohammed","family":"Zayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-9994","authenticated-orcid":false,"given":"Byung-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"6219_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","volume":"19","author":"PJ Magistretti","year":"2018","unstructured":"Magistretti PJ, Allaman I (2018) Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci 19:235\u2013249. https:\/\/doi.org\/10.1038\/nrn.2018.19","journal-title":"Nat Rev Neurosci"},{"key":"6219_CR2","doi-asserted-by":"publisher","first-page":"fcad356","DOI":"10.1093\/braincomms\/fcad356","volume":"6","author":"A Houldsworth","year":"2024","unstructured":"Houldsworth A (2024) Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants. Brain Commun 6:fcad356. https:\/\/doi.org\/10.1093\/braincomms\/fcad356","journal-title":"Brain Commun"},{"key":"6219_CR3","doi-asserted-by":"publisher","first-page":"1475934","DOI":"10.3389\/fncel.2024.1475934","volume":"18","author":"Y Fei","year":"2024","unstructured":"Fei Y, Ding Y (2024) The role of ferroptosis in neurodegenerative diseases. Front Cell Neurosci 18:1475934. https:\/\/doi.org\/10.3389\/fncel.2024.1475934","journal-title":"Front Cell Neurosci"},{"key":"6219_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104155","volume":"93","author":"M Zayed","year":"2026","unstructured":"Zayed M, Tayara H, Jeong B-H (2026) Ferroptosis-related mechanisms in prion diseases provide insights into neurodegeneration and reveal therapeutic implications. Redox Biol 93:104155. https:\/\/doi.org\/10.1016\/j.redox.2026.104155","journal-title":"Redox Biol"},{"key":"6219_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein & Cell 12:599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein & Cell"},{"key":"6219_CR6","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1523\/JNEUROSCI.3178-06.2006","volume":"26","author":"AY Shih","year":"2006","unstructured":"Shih AY, Erb H, Sun X et al (2006) Cystine\/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26:10514\u201310523. https:\/\/doi.org\/10.1523\/JNEUROSCI.3178-06.2006","journal-title":"J Neurosci"},{"key":"6219_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y et al (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25:404\u2013414. https:\/\/doi.org\/10.1038\/s41556-023-01091-2","journal-title":"Nat Cell Biol"},{"key":"6219_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.redox.2017.03.022","volume":"12","author":"JN Cobley","year":"2017","unstructured":"Cobley JN, Close GL, Bailey DM et al (2017) Exercise redox biochemistry: conceptual, methodological and technical recommendations. Redox Biol 12:540\u2013548. https:\/\/doi.org\/10.1016\/j.redox.2017.03.022","journal-title":"Redox Biol"},{"key":"6219_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1873-3468.12964","volume":"592","author":"PR Angelova","year":"2018","unstructured":"Angelova PR, Abramov AY (2018) Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett 592:692\u2013702. https:\/\/doi.org\/10.1002\/1873-3468.12964","journal-title":"FEBS Lett"},{"key":"6219_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1124\/pr.110.003889","volume":"64","author":"R Bridges","year":"2012","unstructured":"Bridges R, Lutgen V, Lobner D et al (2012) Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (system x) to normal and pathological glutamatergic signaling. Pharmacol Rev 64:780\u2013802. https:\/\/doi.org\/10.1124\/pr.110.003889","journal-title":"Pharmacol Rev"},{"key":"6219_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12964-025-02447-x","volume":"23","author":"H Qiu","year":"2025","unstructured":"Qiu H, Liu J, Shao N et al (2025) SLC7A11 as a bridge between ferroptosis and disulfidptosis: a promising target for tumor treatment. Cell Commun Signal 23:460. https:\/\/doi.org\/10.1186\/s12964-025-02447-x","journal-title":"Cell Commun Signal"},{"key":"6219_CR12","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","volume":"274","author":"H Sato","year":"1999","unstructured":"Sato H, Tamba M, Ishii T et al (1999) Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455\u201311458. https:\/\/doi.org\/10.1074\/jbc.274.17.11455","journal-title":"J Biol Chem"},{"key":"6219_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s004240100537","volume":"442","author":"MT Bassi","year":"2001","unstructured":"Bassi MT, Gasol E, Manzoni M et al (2001) Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc. Pflugers Arch 442:286\u2013296. https:\/\/doi.org\/10.1007\/s004240100537","journal-title":"Pflugers Arch"},{"key":"6219_CR14","doi-asserted-by":"publisher","unstructured":"Lewerenz J, Hewett SJ, Huang Y et al (2013) The cystine\/glutamate antiporter system x\u2212 in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal18:522\u2013555. https:\/\/doi.org\/10.1089\/ars.2011.4391","DOI":"10.1089\/ars.2011.4391"},{"key":"6219_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2016.12.013","volume":"136","author":"CR Rose","year":"2018","unstructured":"Rose CR, Ziemens D, Untiet V et al (2018) Molecular and cellular physiology of sodium-dependent glutamate transporters. Brain Res Bull 136:3\u201316. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.12.013","journal-title":"Brain Res Bull"},{"key":"6219_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682\u2013696. https:\/\/doi.org\/10.1038\/nrn2911","journal-title":"Nat Rev Neurosci"},{"key":"6219_CR17","doi-asserted-by":"publisher","first-page":"1559423","DOI":"10.3389\/fcell.2025.1559423","volume":"13","author":"W-W Zhu","year":"2025","unstructured":"Zhu W-W, Liu Y, Yu Z et al (2025) SLC7A11-mediated cell death mechanism in cancer: a comparative study of disulfidptosis and ferroptosis. Front Cell Dev Biol 13:1559423. https:\/\/doi.org\/10.3389\/fcell.2025.1559423","journal-title":"Front Cell Dev Biol"},{"key":"6219_CR18","doi-asserted-by":"publisher","unstructured":"Gasol E, Jim\u00e9nez-Vidal M, Chillar\u00f3n J et al (2004) Membrane topology of system xc- light subunit reveals a re-entrant loop with substrate-restricted accessibility. J Biol Chem 279:31228\u201331236. https:\/\/doi.org\/10.1074\/jbc.M402428200","DOI":"10.1074\/jbc.M402428200"},{"key":"6219_CR19","doi-asserted-by":"publisher","first-page":"15074","DOI":"10.1038\/ncomms15074","volume":"8","author":"C-S Shin","year":"2017","unstructured":"Shin C-S, Mishra P, Watrous JD et al (2017) The glutamate\/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat Commun 8:15074. https:\/\/doi.org\/10.1038\/ncomms15074","journal-title":"Nat Commun"},{"key":"6219_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.gendis.2020.11.010","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu X, Zhang Y, Zhuang L et al (2021) NADPH debt drives redox bankruptcy: SLC7A11\/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation. Genes Dis 8:731\u2013745. https:\/\/doi.org\/10.1016\/j.gendis.2020.11.010","journal-title":"Genes Dis"},{"key":"6219_CR21","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/ijms21082676","volume":"21","author":"C-H Chang","year":"2020","unstructured":"Chang C-H, Lin C-H, Lane H-Y (2020) D-glutamate and gut microbiota in Alzheimer\u2019s disease. Int J Mol Sci 21:2676. https:\/\/doi.org\/10.3390\/ijms21082676","journal-title":"Int J Mol Sci"},{"key":"6219_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2024.200160","volume":"5","author":"L Li","year":"2024","unstructured":"Li L, Jin W, Lu J et al (2024) The involvement of Slc7a11\/xCT related iron accumulation on acupuncture intervention in 6-OHDA-induced Parkinson rat. Clin Tradit Med Pharmacol 5:200160. https:\/\/doi.org\/10.1016\/j.ctmp.2024.200160","journal-title":"Clin Tradit Med Pharmacol"},{"key":"6219_CR23","doi-asserted-by":"publisher","unstructured":"Qin S, Colin C, Hinners I et al (2006) System xc\u2212 and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-\u03b2 peptide 1\u201340. J Neurosci 26:3345\u20133356. https:\/\/doi.org\/10.1523\/JNEUROSCI.5186-05.2006","DOI":"10.1523\/JNEUROSCI.5186-05.2006"},{"key":"6219_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115021","volume":"289","author":"C Fu","year":"2022","unstructured":"Fu C, Wu Y, Liu S et al (2022) Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K\/AKT\/Nrf2 and SLC7A11\/GPX4 signaling pathway after ischemia. JEthnopharmacol 289:115021. https:\/\/doi.org\/10.1016\/j.jep.2022.115021","journal-title":"JEthnopharmacol"},{"key":"6219_CR25","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/cancers14133059","volume":"14","author":"S Li","year":"2022","unstructured":"Li S, Lu Z, Sun R et al (2022) The role of SLC7A11 in cancer: friend or foe? Cancers 14:3059. https:\/\/doi.org\/10.3390\/cancers14133059","journal-title":"Cancers"},{"key":"6219_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"6219_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216619","volume":"584","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang Y, Shen N et al (2024) AMPK\u03b11-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Cancer Lett 584:216619. https:\/\/doi.org\/10.1016\/j.canlet.2024.216619","journal-title":"Cancer Lett"},{"key":"6219_CR28","doi-asserted-by":"publisher","first-page":"2408789","DOI":"10.1002\/advs.202408789","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, Chen J, Fan K et al (2025) Inhibition of endoplasmic reticulum stress cooperates with SLC7A11 to promote disulfidptosis and suppress tumor growth upon glucose limitation. Adv Sci 12:2408789. https:\/\/doi.org\/10.1002\/advs.202408789","journal-title":"Adv Sci"},{"key":"6219_CR29","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/glia.23294","volume":"66","author":"S Ottestad-Hansen","year":"2018","unstructured":"Ottestad-Hansen S, Hu QX, Follin-Arbelet VV et al (2018) The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain. Glia 66:951\u2013970. https:\/\/doi.org\/10.1002\/glia.23294","journal-title":"Glia"},{"key":"6219_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1523\/jneurosci.19-02-00562.1999","volume":"19","author":"R Dringen","year":"1999","unstructured":"Dringen R, Pfeiffer B, Hamprecht B (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19:562\u2013569. https:\/\/doi.org\/10.1523\/jneurosci.19-02-00562.1999","journal-title":"J Neurosci"},{"key":"6219_CR31","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1046\/j.1432-1327.2000.01597.x","volume":"267","author":"R Dringen","year":"2000","unstructured":"Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912\u20134916. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01597.x","journal-title":"Eur J Biochem"},{"key":"6219_CR32","doi-asserted-by":"publisher","first-page":"1514253","DOI":"10.3389\/fnins.2025.1514253","volume":"19","author":"J Chang","year":"2025","unstructured":"Chang J, Liu D, Xiao Y et al (2025) Disulfidptosis: a new target for central nervous system disease therapy. Front Neurosci 19:1514253. https:\/\/doi.org\/10.3389\/fnins.2025.1514253","journal-title":"Front Neurosci"},{"key":"6219_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H-l et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"key":"6219_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s13679-025-00669-1","volume":"14","author":"M Zayed","year":"2025","unstructured":"Zayed M, Massoud A, Hassan F et al (2025) Harnessing adipose ferroptosis: a promising novel pathway for obesity treatment. Curr Obes Rep 14:74. https:\/\/doi.org\/10.1007\/s13679-025-00669-1","journal-title":"Curr Obes Rep"},{"key":"6219_CR35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T et al (2020) ATF3 promotes erastin-induced ferroptosis by suppressing system Xc-. Cell Death Differ 27:662\u2013675. https:\/\/doi.org\/10.1038\/s41418-019-0380-z","journal-title":"Cell Death Differ"},{"key":"6219_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y et al (2024) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512. https:\/\/doi.org\/10.1016\/j.biopha.2024.116512","journal-title":"Biomed Pharmacother"},{"key":"6219_CR37","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1080\/21655979.2021.1995994","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Wu B, Zhong B et al (2021) Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) \/system xc-\/ glutathion eperoxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 12:10924\u201310934. https:\/\/doi.org\/10.1080\/21655979.2021.1995994","journal-title":"Bioengineered"},{"key":"6219_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino M, Conrad M, Ursini F (2018) GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal 29:61\u201374. https:\/\/doi.org\/10.1089\/ars.2017.7115","journal-title":"Antioxid Redox Signal"},{"key":"6219_CR39","first-page":"1933","volume":"8","author":"S Wang","year":"2018","unstructured":"Wang S, Luo J, Zhang Z et al (2018) Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Am J Cancer Res 8:1933\u20131946","journal-title":"Am J Cancer Res"},{"key":"6219_CR40","doi-asserted-by":"publisher","first-page":"18144","DOI":"10.1038\/s41598-020-74646-0","volume":"10","author":"T Tsuneda","year":"2020","unstructured":"Tsuneda T (2020) Fenton reaction mechanism generating no OH radicals in Nafion membrane decomposition. Sci Rep 10:18144. https:\/\/doi.org\/10.1038\/s41598-020-74646-0","journal-title":"Sci Rep"},{"key":"6219_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","volume":"12","author":"WS Hambright","year":"2017","unstructured":"Hambright WS, Fonseca RS, Chen L et al (2017) Ablation of ferroptosis regulator glutathion eperoxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol 12:8\u201317. https:\/\/doi.org\/10.1016\/j.redox.2017.01.021","journal-title":"Redox Biol"},{"key":"6219_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111459","volume":"412","author":"Q Lu","year":"2025","unstructured":"Lu Q, Shao N, Fang Z et al (2025) The anti-Alzheimer\u2019s disease effects of ganoderic acid A by inhibiting ferroptosis-lipid peroxidation via activation of the NRF2\/SLC7A11\/GPX4 signaling pathway. Chem Biol Interact 412:111459. https:\/\/doi.org\/10.1016\/j.cbi.2025.111459","journal-title":"Chem Biol Interact"},{"key":"6219_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10337-012-2237-1","volume":"75","author":"M Giera","year":"2012","unstructured":"Giera M, Lingeman H, Niessen WM (2012) Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): A brief overview. Chromatographia 75:433\u2013440. https:\/\/doi.org\/10.1007\/s10337-012-2237-1","journal-title":"Chromatographia"},{"key":"6219_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101858","volume":"13","author":"Y Guo","year":"2025","unstructured":"Guo Y, Jiang Q, Gu Z et al (2025) ACSL4 in Alzheimer's disease: Pathogenetic mechanisms and potential therapeutic targets. Genes Dis 13:101858. https:\/\/doi.org\/10.1016\/j.gendis.2025.101858","journal-title":"Genes Dis"},{"key":"6219_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117196","volume":"319","author":"Q-M Li","year":"2024","unstructured":"Li Q-M, Xu T, Zha X-Q et al (2024) Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson\u2019s disease. J Ethnopharmacol 319:117196. https:\/\/doi.org\/10.1016\/j.jep.2023.117196","journal-title":"J Ethnopharmacol"},{"key":"6219_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.freeradbiomed.2024.06.020","volume":"222","author":"Z Yao","year":"2024","unstructured":"Yao Z, Jia F, Wang S et al (2024) The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson\u2019s disease. Free Radical Biol Med 222:386\u2013396. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.06.020","journal-title":"Free Radical Biol Med"},{"key":"6219_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147216","volume":"1752","author":"W Chen","year":"2021","unstructured":"Chen W, Jiang L, Hu Y et al (2021) Ferritin reduction is essential for cerebral ischemia-induced hippocampal neuronal death through p53\/SLC7A11-mediated ferroptosis. Brain Res 1752:147216. https:\/\/doi.org\/10.1016\/j.brainres.2020.147216","journal-title":"Brain Res"},{"key":"6219_CR48","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.4103\/NRR.NRR-D-24-00025","volume":"20","author":"R Song","year":"2025","unstructured":"Song R, Yin S, Wu J et al (2025) Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials. Neural Regen Res 20:2245\u20132263. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00025","journal-title":"Neural Regen Res"},{"key":"6219_CR49","doi-asserted-by":"publisher","first-page":"1236490","DOI":"10.3389\/fnagi.2023.1236490","volume":"15","author":"S Ma","year":"2023","unstructured":"Ma S, Wang D, Xie D (2023) Identification of disulfidptosis-related genes and subgroups in Alzheimer\u2019s disease. Front Aging Neurosci 15:1236490. https:\/\/doi.org\/10.3389\/fnagi.2023.1236490","journal-title":"Front Aging Neurosci"},{"key":"6219_CR50","doi-asserted-by":"publisher","first-page":"1398802","DOI":"10.3389\/fimmu.2024.1398802","volume":"15","author":"K Zhang","year":"2024","unstructured":"Zhang K, Li G, Wang Q et al (2024) A disulfidptosis-related glucose metabolism and immune response prognostic model revealing the immune microenvironment in lung adenocarcinoma. Front Immunol 15:1398802. https:\/\/doi.org\/10.3389\/fimmu.2024.1398802","journal-title":"Front Immunol"},{"key":"6219_CR51","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472:1299\u20131343. https:\/\/doi.org\/10.1007\/s00424-020-02441-x","journal-title":"Pflugers Arch"},{"key":"6219_CR52","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa T, Ralser M, Fan J et al (2023) The pentose phosphate pathway in health and disease. Nat Metab 5:1275\u20131289. https:\/\/doi.org\/10.1038\/s42255-023-00863-2","journal-title":"Nat Metab"},{"key":"6219_CR53","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1038\/s41467-024-53389-w","volume":"15","author":"ET Schmid","year":"2024","unstructured":"Schmid ET, Schinaman JM, Liu-Abramowicz N et al (2024) Accumulation of F-actin drives brain aging and healthspan in drosophila. Nat Commun 15:9238. https:\/\/doi.org\/10.1038\/s41467-024-53389-w","journal-title":"Nat Commun"},{"key":"6219_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13195-024-01558-w","volume":"16","author":"PA Haseena","year":"2024","unstructured":"Haseena PA, Basavaraju N, Chandran M et al (2024) Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 16:200. https:\/\/doi.org\/10.1186\/s13195-024-01558-w","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"6219_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41436-020-01011-x","volume":"23","author":"A Begemann","year":"2021","unstructured":"Begemann A, Sticht H, Begtrup A et al (2021) New insights into the clinical and molecular spectrum of the novel CYFIP2-related neurodevelopmental disorder and impairment of the WRC-mediated actin dynamics. Genet Med 23:543\u2013554. https:\/\/doi.org\/10.1038\/s41436-020-01011-x","journal-title":"Genet Med"},{"key":"6219_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12964-024-01871-9","volume":"22","author":"T Li","year":"2024","unstructured":"Li T, Song Y, Wei L et al (2024) Disulfidptosis: A novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics. Cell Commun Signal 22:491. https:\/\/doi.org\/10.1186\/s12964-024-01871-9","journal-title":"Cell Commun Signal"},{"key":"6219_CR57","doi-asserted-by":"publisher","first-page":"20185","DOI":"10.1038\/s41598-024-70893-7","volume":"14","author":"L Huang","year":"2024","unstructured":"Huang L, Li Z, Lv Y et al (2024) Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer\u2019s disease. Sci Rep 14:20185. https:\/\/doi.org\/10.1038\/s41598-024-70893-7","journal-title":"Sci Rep"},{"key":"6219_CR58","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.4103\/nrr.Nrr-d-25-00024","volume":"21","author":"W Ye","year":"2025","unstructured":"Ye W, Zhang Q, Ge W et al (2025) Disulfidptosis contributes to rotenone-induced dopaminergic neuron damage. Neural Regen Res 21:4435\u20134446. https:\/\/doi.org\/10.4103\/nrr.Nrr-d-25-00024","journal-title":"Neural Regen Res"},{"key":"6219_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13041-025-01200-2","volume":"18","author":"J Zhang","year":"2025","unstructured":"Zhang J, Liu T, Wu H et al (2025) Target oxidative stress-induced disulfidptosis: Novel therapeutic avenues in Parkinson\u2019s disease. Mol Brain 18:29. https:\/\/doi.org\/10.1186\/s13041-025-01200-2","journal-title":"Mol Brain"},{"key":"6219_CR60","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.3390\/cimb46090600","volume":"46","author":"T Liu","year":"2024","unstructured":"Liu T, Kong X, Wei J (2024) Disulfidptosis: a new target for Parkinson\u2019s disease and cancer. Curr Issues Mol Biol 46:10038\u201310064. https:\/\/doi.org\/10.3390\/cimb46090600","journal-title":"Curr Issues Mol Biol"},{"key":"6219_CR61","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/0115672026286243240105115419","volume":"20","author":"S-p Liu","year":"2023","unstructured":"Liu S-p, Liu C, Xu B et al (2023) Disulfidptosis and its role in peripheral blood immune cells after a stroke: a new frontier in stroke pathogenesis. Curr Neurovasc Res 20:608\u2013622. https:\/\/doi.org\/10.2174\/0115672026286243240105115419","journal-title":"Curr Neurovasc Res"},{"key":"6219_CR62","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/biom11070923","volume":"11","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Zhai Y, Chen J et al (2021) Kaempferol ameliorates oxygen-glucose deprivation\/reoxygenation-induced neuronal ferroptosis by activating Nrf2\/SLC7A11\/GPX4 axis. Biomolecules 11:923. https:\/\/doi.org\/10.3390\/biom11070923","journal-title":"Biomolecules"},{"key":"6219_CR63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486\u2013510. https:\/\/doi.org\/10.1007\/s00259-005-1762-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6219_CR64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","volume":"1","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Z, Hoshino A et al (2019) NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab 1:404\u2013415. https:\/\/doi.org\/10.1038\/s42255-019-0043-x","journal-title":"Nat Metab"},{"key":"6219_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/antiox11020405","volume":"11","author":"G Goldsteins","year":"2022","unstructured":"Goldsteins G, Hakosalo V, Jaronen M et al (2022) CNS redox homeostasis and dysfunction in neurodegenerative diseases. Antioxidants 11:405. https:\/\/doi.org\/10.3390\/antiox11020405","journal-title":"Antioxidants"},{"key":"6219_CR66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","volume":"13","author":"E Liu","year":"2024","unstructured":"Liu E, Zhang Y, Wang J-Z et al (2024) Updates in Alzheimer's disease: From basic research to diagnosis and therapies. Transl Neurodegener 13:45. https:\/\/doi.org\/10.1186\/s40035-024-00432-x","journal-title":"Transl Neurodegener"},{"key":"6219_CR67","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","volume":"17","author":"AR Roda","year":"2022","unstructured":"Roda AR, Serra-Mir G, Montoliu-Gaya L et al (2022) Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease. Neural Regener Res 17:1666\u20131674. https:\/\/doi.org\/10.4103\/1673-5374.332127","journal-title":"Neural Regener Res"},{"key":"6219_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.530219","volume":"14","author":"X Yan","year":"2020","unstructured":"Yan X, Hu Y, Wang B et al (2020) Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease. Front Neurosci 14:530219. https:\/\/doi.org\/10.3389\/fnins.2020.530219","journal-title":"Front Neurosci"},{"key":"6219_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nut.2010.07.021","volume":"27","author":"S Cunnane","year":"2011","unstructured":"Cunnane S, Nugent S, Roy M et al (2011) Brain fuel metabolism, aging, and Alzheimer\u2019s disease. Nutrition 27:3\u201320. https:\/\/doi.org\/10.1016\/j.nut.2010.07.021","journal-title":"Nutrition"},{"key":"6219_CR70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.14283\/jpad.2023.91","volume":"11","author":"V Patel","year":"2023","unstructured":"Patel V, Mill J, Okonkwo OC et al (2023) Global energy metabolism deficit in Alzheimer disease brain. J Prev Alzheimer's Dis 11:171\u2013178. https:\/\/doi.org\/10.14283\/jpad.2023.91","journal-title":"J Prev Alzheimer's Dis"},{"key":"6219_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/JAD-122449","volume":"41","author":"V Tiwari","year":"2014","unstructured":"Tiwari V, Patel AB, Vivek Tiwari ABP (2014) Pyruvate carboxylase and pentose phosphate fluxes are reduced in A\u03b2PP-PS1 mouse model of Alzheimer's disease: A 13c nmr study. J Alzheimer\u2019s Dis 41:387\u2013399. https:\/\/doi.org\/10.3233\/JAD-122449","journal-title":"J Alzheimer\u2019s Dis"},{"key":"6219_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita L, Chung SY, Shim J-w et al (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10:53. https:\/\/doi.org\/10.1186\/s13041-017-0340-9","journal-title":"Mol Brain"},{"key":"6219_CR73","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/biom14121649","volume":"14","author":"L Shen","year":"2024","unstructured":"Shen L, Dettmer U (2024) Alpha-synuclein effects on mitochondrial quality control in Parkinson\u2019s disease. Biomolecules 14:1649. https:\/\/doi.org\/10.3390\/biom14121649","journal-title":"Biomolecules"},{"key":"6219_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.875059","volume":"14","author":"D-n Li","year":"2022","unstructured":"Li D-n, Lian T-h, Zhang W-J et al (2022) Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms. Front Aging Neurosci 14:875059. https:\/\/doi.org\/10.3389\/fnagi.2022.875059","journal-title":"Front Aging Neurosci"},{"key":"6219_CR75","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-017-0225-5","volume":"12","author":"K Belarbi","year":"2017","unstructured":"Belarbi K, Cuvelier E, Dest\u00e9e A et al (2017) NADPH oxidases in Parkinson\u2019s disease: a systematic review. Mol Neurodegener 12:84. https:\/\/doi.org\/10.1186\/s13024-017-0225-5","journal-title":"Mol Neurodegener"},{"key":"6219_CR76","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.14336\/AD.2025.0619","volume":"16","author":"M Pokotylo","year":"2025","unstructured":"Pokotylo M, Br\u00fcggemann N, Prasuhn J et al (2025) Metabolic dysregulation in Parkinson\u2019s disease: Non-oxidative phosphorylation and its role in brain energy metabolism. Aging Dis 16:2721\u20132738. https:\/\/doi.org\/10.14336\/AD.2025.0619","journal-title":"Aging Dis"},{"key":"6219_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165228","volume":"133","author":"J Sun","year":"2023","unstructured":"Sun J, Lin X-M, Lu D-H et al (2023) Midbrain dopamine oxidation links ubiquitination of glutathion eperoxidase 4 to ferroptosis of dopaminergic neurons. J Clin Investig 133:e165228. https:\/\/doi.org\/10.1172\/JCI165228","journal-title":"J Clin Investig"},{"key":"6219_CR78","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s10020-025-01208-3","volume":"31","author":"Y Chen","year":"2025","unstructured":"Chen Y, Luo X, Yin Y et al (2025) The interplay of iron, oxidative stress, and \u03b1-synuclein in Parkinson\u2019s disease progression. Mol Med 31:154. https:\/\/doi.org\/10.1186\/s10020-025-01208-3","journal-title":"Mol Med"},{"key":"6219_CR79","doi-asserted-by":"publisher","first-page":"37060","DOI":"10.1007\/s11356-021-14619-6","volume":"28","author":"I Kaur","year":"2021","unstructured":"Kaur I, Behl T, Sehgal A et al (2021) Connecting the dots between mitochondrial dysfunction and Parkinson\u2019s disorder: Focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity. Environ Sci Pollut Res 28:37060\u201337081. https:\/\/doi.org\/10.1007\/s11356-021-14619-6","journal-title":"Environ Sci Pollut Res"},{"key":"6219_CR80","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00702-012-0894-8","volume":"119","author":"A Friedman","year":"2012","unstructured":"Friedman A, Galazka-Friedman J (2012) The history of the research of iron in parkinsonian substantia nigra. J Neural Transm 119:1507\u20131510. https:\/\/doi.org\/10.1007\/s00702-012-0894-8","journal-title":"J Neural Transm"},{"key":"6219_CR81","doi-asserted-by":"publisher","first-page":"1528538","DOI":"10.3389\/fphar.2025.1528538","volume":"16","author":"X Guo","year":"2025","unstructured":"Guo X, Wei R, Yin X et al (2025) Crosstalk between neuroinflammation and ferroptosis: Implications for Parkinson\u2019s disease progression. Front Pharmacol 16:1528538. https:\/\/doi.org\/10.3389\/fphar.2025.1528538","journal-title":"Front Pharmacol"},{"key":"6219_CR82","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1871527322666230609141519","volume":"23","author":"A Rasool","year":"2024","unstructured":"Rasool A, Manzoor R, Ullah K et al (2024) Oxidative stress and dopaminergic metabolism: a major PD pathogenic mechanism and basis of potential antioxidant therapies. CNS Neurol Disord Drug Targets 23:852\u2013864. https:\/\/doi.org\/10.2174\/1871527322666230609141519","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"6219_CR83","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1002\/anie.201811122","volume":"58","author":"E Monzani","year":"2019","unstructured":"Monzani E, Nicolis S, Dell'Acqua S et al (2019) Dopamine, oxidative stress and protein\u2013quinone modifications in Parkinson's and other neurodegenerative diseases. Angew Chem Int Ed 58:6512. https:\/\/doi.org\/10.1002\/anie.201811122","journal-title":"Angew Chem Int Ed"},{"key":"6219_CR84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-016-0060-6","volume":"5","author":"Q Hu","year":"2016","unstructured":"Hu Q, Wang G (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. Transl Neurodegener 5:14. https:\/\/doi.org\/10.1186\/s40035-016-0060-6","journal-title":"Transl Neurodegener"},{"key":"6219_CR85","doi-asserted-by":"publisher","first-page":"17027","DOI":"10.3390\/ijms242317027","volume":"24","author":"C-J Choong","year":"2023","unstructured":"Choong C-J, Mochizuki H (2023) Involvement of mitochondria in Parkinson\u2019s disease. Int J Mol Sci 24:17027. https:\/\/doi.org\/10.3390\/ijms242317027","journal-title":"Int J Mol Sci"},{"key":"6219_CR86","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.neuroscience.2007.08.028","volume":"149","author":"S Vali","year":"2007","unstructured":"Vali S, Mythri RB, Jagatha B et al (2007) Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson\u2019s disease: a dynamic model. Neurosci 149:917\u2013930. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.08.028","journal-title":"Neurosci"},{"key":"6219_CR87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","volume":"133","author":"A Anandhan","year":"2017","unstructured":"Anandhan A, Jacome MS, Lei S et al (2017) Metabolic disorder dysfunction in Parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism. Brain Res Bull 133:12\u201330. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.03.009","journal-title":"Brain Res Bull"},{"key":"6219_CR88","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s11064-024-04116-w","volume":"49","author":"J Shen","year":"2024","unstructured":"Shen J, Chen S, Li X et al (2024) Salidroside mediated the Nrf2\/GPX4 pathway to attenuates ferroptosis in Parkinson\u2019s disease. Neurochem Res 49:1291\u20131305. https:\/\/doi.org\/10.1007\/s11064-024-04116-w","journal-title":"Neurochem Res"},{"key":"6219_CR89","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.3390\/ijms252313042","volume":"25","author":"M Zhou","year":"2024","unstructured":"Zhou M, Xu K, Ge J et al (2024) Targeting ferroptosis in Parkinson\u2019s disease: Mechanisms and emerging therapeutic strategies. Int J Mol Sci 25:13042. https:\/\/doi.org\/10.3390\/ijms252313042","journal-title":"Int J Mol Sci"},{"key":"6219_CR90","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Damme PV (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27:1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"key":"6219_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15:45. https:\/\/doi.org\/10.1186\/s13024-020-00397-1","journal-title":"Mol Neurodegener"},{"key":"6219_CR92","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/cells9122687","volume":"9","author":"A Yousefian-Jazi","year":"2020","unstructured":"Yousefian-Jazi A, Seol Y, Kim J et al (2020) Pathogenic genome signatures that damage motor neurons in amyotrophic lateral sclerosis. Cells 9:2687. https:\/\/doi.org\/10.3390\/cells9122687","journal-title":"Cells"},{"key":"6219_CR93","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A et al (2022) Emerging insights into the complex genetics and pathophysiology of ALS. The Lancet Neurol 21:465\u2013479. https:\/\/doi.org\/10.1016\/S1474-4422(21)00414-2","journal-title":"The Lancet Neurol"},{"key":"6219_CR94","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/cells12151948","volume":"12","author":"E Bagyinszky","year":"2023","unstructured":"Bagyinszky E, Hulme J, An SSA et al (2023) Studies of genetic and proteomic risk factors of amyotrophic lateral sclerosis inspire biomarker development and gene therapy. Cells 12:1948. https:\/\/doi.org\/10.3390\/cells12151948","journal-title":"Cells"},{"key":"6219_CR95","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/cells13030248","volume":"13","author":"T Cunha-Oliveira","year":"2024","unstructured":"Cunha-Oliveira T, Montezinho L, Sim\u00f5es RF et al (2024) Mitochondria: A promising convergent target for the treatment of amyotrophic lateral sclerosis. Cells 13:248. https:\/\/doi.org\/10.3390\/cells13030248","journal-title":"Cells"},{"key":"6219_CR96","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","volume":"29","author":"T Wang","year":"2021","unstructured":"Wang T, Tomas D, Perera ND et al (2021) Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death Differ 29:1187\u20131198. https:\/\/doi.org\/10.1038\/s41418-021-00910-z","journal-title":"Cell Death Differ"},{"key":"6219_CR97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/biology13040215","volume":"13","author":"M Ismail","year":"2024","unstructured":"Ismail M, Gro\u00dfmann D, Hermann A et al (2024) Increased vulnerability to ferroptosis in FUS-ALS. Biology 13:215. https:\/\/doi.org\/10.3390\/biology13040215","journal-title":"Biology"},{"key":"6219_CR98","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41418-022-01089-7","volume":"30","author":"D Wang","year":"2022","unstructured":"Wang D, Liang W, Huo D et al (2022) SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1. Cell Death Differ 30:369\u2013382. https:\/\/doi.org\/10.1038\/s41418-022-01089-7","journal-title":"Cell Death Differ"},{"key":"6219_CR99","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbrc.2021.05.095","volume":"566","author":"T Matsuo","year":"2021","unstructured":"Matsuo T, Adachi-Tominari K, Sano O et al (2021) Involvement of ferroptosis in human motor neuron cell death. Biochem Biophys Res Commun 566:24\u201329. https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.095","journal-title":"Biochem Biophys Res Commun"},{"key":"6219_CR100","doi-asserted-by":"publisher","unstructured":"Yang B, Pan J, Zhang X-N et al (2023) NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1G93A mutation and exerts neuroprotection in amyotrophic lateral sclerosis. Neurobiol Dis184:106210. https:\/\/doi.org\/10.1016\/j.nbd.2023.106210","DOI":"10.1016\/j.nbd.2023.106210"},{"key":"6219_CR101","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1093\/brain\/awz201","volume":"142","author":"M Wentling","year":"2019","unstructured":"Wentling M, Lopez-Gomez C, Park H-J et al (2019) A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis. Brain 142:2756\u20132774. https:\/\/doi.org\/10.1093\/brain\/awz201","journal-title":"Brain"},{"key":"6219_CR102","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H (2018) Multiple sclerosis pathology. Cold Spring Harbor Perspect Med 8:a028936. https:\/\/doi.org\/10.1101\/cshperspect.a028936","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"6219_CR103","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider L, Fischer MT, Frischer JM et al (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914\u20131924. https:\/\/doi.org\/10.1093\/brain\/awr128","journal-title":"Brain"},{"key":"6219_CR104","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/brain\/aws012","volume":"135","author":"MT Fischer","year":"2012","unstructured":"Fischer MT, Sharma R, Lim JL et al (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135:886\u2013899. https:\/\/doi.org\/10.1093\/brain\/aws012","journal-title":"Brain"},{"key":"6219_CR105","doi-asserted-by":"publisher","first-page":"20926","DOI":"10.1038\/srep20926","volume":"6","author":"M Di Filippo","year":"2016","unstructured":"Di Filippo M, de Iure A, Giamp\u00e0 C et al (2016) Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis. Sci Rep 6:20926. https:\/\/doi.org\/10.1038\/srep20926","journal-title":"Sci Rep"},{"key":"6219_CR106","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/ijms17010100","volume":"17","author":"C St\u00fcber","year":"2016","unstructured":"St\u00fcber C, Pitt D, Wang Y et al (2016) Iron in multiple sclerosis and its noninvasive imaging with quantitative susceptibility mapping. Int J Mol Sci 17:100. https:\/\/doi.org\/10.3390\/ijms17010100","journal-title":"Int J Mol Sci"},{"key":"6219_CR107","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ana.23974","volume":"74","author":"S Hametner","year":"2013","unstructured":"Hametner S, Wimmer I, Haider L et al (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848\u2013861. https:\/\/doi.org\/10.1002\/ana.23974","journal-title":"Ann Neurol"},{"key":"6219_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-017-1697-7","volume":"134","author":"R van den Berg","year":"2017","unstructured":"van den Berg R, Hoogenraad CC, Hintzen RQ (2017) Axonal transport deficits in multiple sclerosis: spiraling into the abyss. Acta Neuropathol 134:1\u201314. https:\/\/doi.org\/10.1007\/s00401-017-1697-7","journal-title":"Acta Neuropathol"},{"key":"6219_CR109","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","volume":"38","author":"J Labbadia","year":"2013","unstructured":"Labbadia J, Morimoto RI (2013) Huntington's disease: Underlying molecular mechanisms and emerging concepts. Trends Bioch Sci 38:378\u2013385. https:\/\/doi.org\/10.1016\/j.tibs.2013.05.003","journal-title":"Trends Bioch Sci"},{"key":"6219_CR110","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.3390\/ijms262210907","volume":"26","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang S, Wang C et al (2025) Post-translational modifications of huntingtin: mechanistic insights and therapeutic opportunities in Huntington\u2019s disease. Int J Mol Sci 26:10907. https:\/\/doi.org\/10.3390\/ijms262210907","journal-title":"Int J Mol Sci"},{"key":"6219_CR111","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","volume":"22","author":"M Damiano","year":"2013","unstructured":"Damiano M, Diguet E, Malgorn C et al (2013) A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Mol Genet 22:3869\u20133882. https:\/\/doi.org\/10.1093\/hmg\/ddt242","journal-title":"Human Mol Genet"},{"key":"6219_CR112","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GVW, MacDonald M et al (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Human Mol Genet 13:1407\u20131420. https:\/\/doi.org\/10.1093\/hmg\/ddh162","journal-title":"Human Mol Genet"},{"key":"6219_CR113","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","volume":"231","author":"IL Ferreira","year":"2011","unstructured":"Ferreira IL, Cunha-Oliveira T, Nascimento MV et al (2011) Bioenergetic dysfunction in Huntington's disease human cybrids. Exp Neurol 231:127\u2013134. https:\/\/doi.org\/10.1016\/j.expneurol.2011.05.024","journal-title":"Exp Neurol"},{"key":"6219_CR114","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JHD-170264","volume":"6","author":"JM Dubinsky","year":"2017","unstructured":"Dubinsky JM (2017) Towards an understanding of energy impairment in Huntington\u2019s disease brain. JHuntington's Dis 6:267\u2013302. https:\/\/doi.org\/10.3233\/JHD-170264","journal-title":"JHuntington's Dis"},{"key":"6219_CR115","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1523\/JNEUROSCI.5865-09.2010","volume":"30","author":"X Li","year":"2010","unstructured":"Li X, Valencia A, Sapp E et al (2010) Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease. J Neurosci 30:4552\u20134561. https:\/\/doi.org\/10.1523\/JNEUROSCI.5865-09.2010","journal-title":"J Neurosci"},{"key":"6219_CR116","doi-asserted-by":"publisher","first-page":"15272","DOI":"10.3390\/ijms232315272","volume":"23","author":"P Tucci","year":"2022","unstructured":"Tucci P, Lattanzi R, Severini C et al (2022) Nrf2 pathway in Huntington\u2019s disease (HD): What is its role? Int J Mol Sci 23:15272. https:\/\/doi.org\/10.3390\/ijms232315272","journal-title":"Int J Mol Sci"},{"key":"6219_CR117","doi-asserted-by":"publisher","unstructured":"van Roon-Mom WM, Pepers BA, \u2019t Hoen PA et al (2008) Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington\u2019s disease. BMC Mol Biol 9:84. https:\/\/doi.org\/10.1186\/1471-2199-9-84","DOI":"10.1186\/1471-2199-9-84"},{"key":"6219_CR118","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.freeradbiomed.2012.09.004","volume":"53","author":"M Ribeiro","year":"2012","unstructured":"Ribeiro M, Rosenstock TR, Cunha-Oliveira T et al (2012) Glutathione redox cycle dysregulation in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med 53:1857\u20131867. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.09.004","journal-title":"Free Radic Biol Med"},{"key":"6219_CR119","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A et al (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J Neurochem 79:1246\u20131249. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00689.x","journal-title":"J Neurochem"},{"key":"6219_CR120","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12967-023-04493-w","volume":"21","author":"FA Bustamante-Barrientos","year":"2023","unstructured":"Bustamante-Barrientos FA, Luque-Campos N, Araya MJ et al (2023) Mitochondrial dysfunction in neurodegenerative disorders: potential therapeutic application of mitochondrial transfer to central nervous system-residing cells. J Transl Med 21:613. https:\/\/doi.org\/10.1186\/s12967-023-04493-w","journal-title":"J Transl Med"},{"key":"6219_CR121","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K et al (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects. Hum Mol Genet 19:3053\u20133067. https:\/\/doi.org\/10.1093\/hmg\/ddq212","journal-title":"Hum Mol Genet"},{"key":"6219_CR122","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","volume":"34","author":"AM Estrada-S\u00e1nchez","year":"2009","unstructured":"Estrada-S\u00e1nchez AM, Montiel T, Segovia J et al (2009) Glutamate toxicity in the striatum of the R6\/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis 34:78\u201386. https:\/\/doi.org\/10.1016\/j.nbd.2008.12.017","journal-title":"Neurobiol Dis"},{"key":"6219_CR123","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddw144","volume":"25","author":"DJ Wright","year":"2016","unstructured":"Wright DJ, Gray LJ, Finkelstein DI et al (2016) N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington\u2019s disease. Human Mol Genet 25:2923\u20132933. https:\/\/doi.org\/10.1093\/hmg\/ddw144","journal-title":"Human Mol Genet"},{"key":"6219_CR124","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1101\/gad.350211.122","volume":"37","author":"S Song","year":"2023","unstructured":"Song S, Su Z, Kon N et al (2023) ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington's disease. Genes & Dev 37:204\u2013217. https:\/\/doi.org\/10.1101\/gad.350211.122","journal-title":"Genes & Dev"},{"key":"6219_CR125","doi-asserted-by":"publisher","first-page":"1593963","DOI":"10.3389\/fncel.2025.1593963","volume":"19","author":"Q Huang","year":"2025","unstructured":"Huang Q, Zhang H, Chen S et al (2025) Ferroptosis in central nervous system injuries: Molecular mechanisms, diagnostic approaches, and therapeutic strategies. Front Cell Neurosci 19:1593963. https:\/\/doi.org\/10.3389\/fncel.2025.1593963","journal-title":"Front Cell Neurosci"},{"key":"6219_CR126","doi-asserted-by":"publisher","unstructured":"Hughes D, Halliday M (2017) What is our current understanding of PrPSc-associated neurotoxicity and its molecular underpinnings? Pathogens 6:63. https:\/\/doi.org\/10.3390\/pathogens6040063","DOI":"10.3390\/pathogens6040063"},{"key":"6219_CR127","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4103\/NRR.NRR-D-24-00181","volume":"20","author":"A Masone","year":"2025","unstructured":"Masone A, Zucchelli C, Caruso E et al (2025) Therapeutic targeting of cellular prion protein: Toward the development of dual mechanism anti-prion compounds. Neural Regener Res 20:1009\u20131014. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00181","journal-title":"Neural Regener Res"},{"key":"6219_CR128","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/cells12192413","volume":"12","author":"M Zayed","year":"2023","unstructured":"Zayed M, Kook SH, Jeong BH (2023) Potential therapeutic use of stem cells for prion diseases. Cells 12:2413. https:\/\/doi.org\/10.3390\/cells12192413","journal-title":"Cells"},{"key":"6219_CR129","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-025-00835-y","volume":"20","author":"M Zayed","year":"2025","unstructured":"Zayed M, Kim Y-C, Jeong B-H (2025) Therapeutic effects of adipose-derived mesenchymal stem cells combined with glymphatic system activation in prion disease. Mol Neurodegener 20:42. https:\/\/doi.org\/10.1186\/s13024-025-00835-y","journal-title":"Mol Neurodegener"},{"key":"6219_CR130","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3390\/cells11172744","volume":"11","author":"M-J Kim","year":"2022","unstructured":"Kim M-J, Kim H-J, Jang B et al (2022) Impairment of neuronal mitochondrial quality control in prion-induced neurodegeneration. Cells 11:2744. https:\/\/doi.org\/10.3390\/cells11172744","journal-title":"Cells"},{"key":"6219_CR131","doi-asserted-by":"publisher","unstructured":"Zhou M, Ottenberg G, Sferrazza GF et al (2015) Neuronal death induced by misfolded prion protein is due to NAD +depletion and can be relieved in vitro and in vivo by NAD +replenishment. Brain138:992-1008. https:\/\/doi.org\/10.1093\/brain\/awv002","DOI":"10.1093\/brain\/awv002"},{"key":"6219_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011309","volume":"19","author":"JG Spiers","year":"2023","unstructured":"Spiers JG, Chen H-JC, Steinert JR (2023) Redox mechanisms and their pathological role in prion diseases: the road to ruin. PLOS Pathogens 19:e1011309. https:\/\/doi.org\/10.1371\/journal.ppat.1011309","journal-title":"PLOS Pathogens"},{"key":"6219_CR133","doi-asserted-by":"publisher","first-page":"e00524","DOI":"10.1128\/jvi.00524-17","volume":"91","author":"R Faris","year":"2017","unstructured":"Faris R, Moore RA, Ward A et al (2017) Mitochondrial respiration is impaired during late-stage hamster prion infection. J Virol 91:e00524\u2013e00517. https:\/\/doi.org\/10.1128\/jvi.00524-17","journal-title":"J Virol"},{"key":"6219_CR134","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41419-025-07390-w","volume":"16","author":"P Wen","year":"2025","unstructured":"Wen P, Sun Z, Yang D et al (2025) Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases. Cell Death Dis 16:66. https:\/\/doi.org\/10.1038\/s41419-025-07390-w","journal-title":"Cell Death Dis"},{"key":"6219_CR135","doi-asserted-by":"publisher","unstructured":"Zayed M, Jeong BH (2025) Mesenchymal stem cell secretome attenuates PrP106\u2013126-induced neurotoxicity by suppressing neuroinflammation and apoptosis and enhances cell migration. Cells 14:851. https:\/\/doi.org\/10.3390\/cells14110851","DOI":"10.3390\/cells14110851"},{"key":"6219_CR136","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s12015-024-10811-6","volume":"21","author":"M Zayed","year":"2025","unstructured":"Zayed M, Jeong BH (2025) Adipose-derived mesenchymal stem cell secretome attenuates prion protein peptide (106\u2013126)-induced oxidative stress via Nrf2 activation. Stem Cell Rev Rep 21:589\u2013592. https:\/\/doi.org\/10.1007\/s12015-024-10811-6","journal-title":"Stem Cell Rev Rep"},{"key":"6219_CR137","doi-asserted-by":"publisher","unstructured":"Zayed M, Kim YC, Jeong BH (2025) Biological characteristics and transcriptomic profile of adipose-derived mesenchymal stem cells isolated from prion-infected murine model. Stem Cell Res Ther16:154. https:\/\/doi.org\/10.1186\/s13287-025-04273-x","DOI":"10.1186\/s13287-025-04273-x"},{"key":"6219_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000336","volume":"5","author":"A Singh","year":"2009","unstructured":"Singh A, Isaac AO, Luo X et al (2009) Abnormal brain iron homeostasis in human and animal prion disorders. PLOS Pathogens 5:e1000336. https:\/\/doi.org\/10.1371\/journal.ppat.1000336","journal-title":"PLOS Pathogens"},{"key":"6219_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004335","volume":"10","author":"N Singh","year":"2014","unstructured":"Singh N (2014) The role of iron in prion disease and other neurodegenerative diseases. PLOS Pathogens 10:e1004335. https:\/\/doi.org\/10.1371\/journal.ppat.1004335","journal-title":"PLOS Pathogens"},{"key":"6219_CR140","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.4103\/NRR.NRR-D-24-00112","volume":"20","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang D, Lin R et al (2025) Pyroptosis, ferroptosis, and autophagy in spinal cord injury: regulatory mechanisms and therapeutic targets. Neural Regener Res 20:2787\u20132806. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00112","journal-title":"Neural Regener Res"},{"key":"6219_CR141","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1038\/s41467-025-60793-3","volume":"16","author":"H Peng","year":"2025","unstructured":"Peng H, Pfeiffer S, Varynskyi B et al (2025) Prion-induced ferroptosis is facilitated by RAC3. Nat Commun 16:5385. https:\/\/doi.org\/10.1038\/s41467-025-60793-3","journal-title":"Nat Commun"},{"key":"6219_CR142","doi-asserted-by":"publisher","first-page":"3972173","DOI":"10.1155\/2022\/3972173","volume":"2022","author":"N Tambasco","year":"2022","unstructured":"Tambasco N, Nigro P, Chiappiniello A et al (2022) An updated overview of the magnetic resonance imaging of brain iron in movement disorders. Behav Neurol 2022:3972173. https:\/\/doi.org\/10.1155\/2022\/3972173","journal-title":"Behav Neurol"},{"key":"6219_CR143","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-12-410502-7.00010-7","volume":"110","author":"P Dusek","year":"2013","unstructured":"Dusek P, Dezortova M, Wuerfel J (2013) Imaging of iron. Int Rev Neurobiol 110:195\u2013239. https:\/\/doi.org\/10.1016\/B978-0-12-410502-7.00010-7","journal-title":"Int Rev Neurobiol"},{"key":"6219_CR144","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3390\/ijms22094479","volume":"22","author":"E Ficiar\u00e0","year":"2021","unstructured":"Ficiar\u00e0 E, Munir Z, Boschi S et al (2021) Alteration of iron concentration in Alzheimer\u2019s disease as a possible diagnostic biomarker unveiling ferroptosis. Int J Mol Sci 22:4479. https:\/\/doi.org\/10.3390\/ijms22094479","journal-title":"Int J Mol Sci"},{"key":"6219_CR145","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jmri.25693","volume":"46","author":"Y Wang","year":"2017","unstructured":"Wang Y, Spincemaille P, Liu Z et al (2017) Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care. J Magn Reson Imaging 46:951\u2013971. https:\/\/doi.org\/10.1002\/jmri.25693","journal-title":"J Magn Reson Imaging"},{"key":"6219_CR146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaneurol.2024.3733","volume":"82","author":"S Ayton","year":"2025","unstructured":"Ayton S, Barton D, Brew B et al (2025) Deferiprone in Alzheimer disease: a randomized clinical trial. JAMA Neurol 82:11\u201318. https:\/\/doi.org\/10.1001\/jamaneurol.2024.3733","journal-title":"JAMA Neurol"},{"key":"6219_CR147","doi-asserted-by":"publisher","unstructured":"Gao Y, Liang C, Zhang Q et al (2025) Brain iron deposition and cognitive decline in patients with cerebral small vessel disease : a quantitative susceptibility mapping study. Alzheimer\u2019s Res Ther17:17. https:\/\/doi.org\/10.1186\/s13195-024-01638-x","DOI":"10.1186\/s13195-024-01638-x"},{"key":"6219_CR148","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neurobiolaging.2019.04.005","volume":"80","author":"N Tambasco","year":"2019","unstructured":"Tambasco N, Paolini Paoletti F, Chiappiniello A et al (2019) T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson\u2019s disease. Neurobiol Aging 80:91\u201398. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.04.005","journal-title":"Neurobiol Aging"},{"key":"6219_CR149","doi-asserted-by":"publisher","unstructured":"van de Zande NA, Bulk M, Najac C et al (2023) Study protocol of IMAGINE-HD: imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington\u2019s disease. Neuroimage Clin39:103450. https:\/\/doi.org\/10.1016\/j.nicl.2023.103450","DOI":"10.1016\/j.nicl.2023.103450"},{"key":"6219_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050706","volume":"7","author":"D Wang","year":"2012","unstructured":"Wang D, Li W-B, Wei X-E et al (2012) An investigation of age-related iron deposition using susceptibility weighted imaging. PLoS ONE 7:e50706. https:\/\/doi.org\/10.1371\/journal.pone.0050706","journal-title":"PLoS ONE"},{"key":"6219_CR151","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neurobiolaging.2006.02.005","volume":"28","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Tishler TA, Lu PH et al (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28:414\u2013423. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.02.005","journal-title":"Neurobiol Aging"},{"key":"6219_CR152","first-page":"166","volume-title":"International review of neurobiology","author":"U Walter","year":"2010","unstructured":"Walter U (2010) Transcranial sonography in brain disorders with trace metal accumulation. In: Berg D, Walter U (eds) International review of neurobiology. Academic Press, pp. 166\u2013178"},{"key":"6219_CR153","first-page":"3","volume-title":"Mitochondria and brain disorders","author":"H Tsukada","year":"2019","unstructured":"Tsukada H (2019) PET imaging of mitochondrial function in the living brain. In: Stavros B (ed) Mitochondria and brain disorders. IntechOpen, London, p. 3"},{"key":"6219_CR154","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13311-012-0161-6","volume":"10","author":"AL Gropman","year":"2013","unstructured":"Gropman AL (2013) Neuroimaging in mitochondrial disorders. Neurotherapeutics 10:273\u2013285. https:\/\/doi.org\/10.1007\/s13311-012-0161-6","journal-title":"Neurotherapeutics"},{"key":"6219_CR155","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/metabo11040233","volume":"11","author":"H Li","year":"2021","unstructured":"Li H, Uittenbogaard M, Hao L et al (2021) Clinical insights into mitochondrial neurodevelopmental and neurodegenerative disorders: their biosignatures from mass spectrometry-based metabolomics. Metabolites 11:233. https:\/\/doi.org\/10.3390\/metabo11040233","journal-title":"Metabolites"},{"key":"6219_CR156","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11306-018-1352-x","volume":"14","author":"D Pan","year":"2018","unstructured":"Pan D, Lindau C, Lagies S et al (2018) Metabolic profiling of isolated mitochondria and cytoplasm reveals compartment-specific metabolic responses. Metabolomics 14:59. https:\/\/doi.org\/10.1007\/s11306-018-1352-x","journal-title":"Metabolomics"},{"key":"6219_CR157","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1097\/rlu.0000000000002791","volume":"44","author":"V Baghel","year":"2019","unstructured":"Baghel V, Tripathi M, Parida G et al (2019) In vivo assessment of Tau deposition in Alzheimer disease and assessing its relationship to regional brain glucose metabolism and cognition. Clin Nucl Med 44:e597\u2013e601. https:\/\/doi.org\/10.1097\/rlu.0000000000002791","journal-title":"Clin Nucl Med"},{"key":"6219_CR158","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/jpd-150583","volume":"5","author":"C Tard","year":"2015","unstructured":"Tard C, Demailly F, Delval A et al (2015) Hypometabolism in posterior and temporal areas of the brain is associated with cognitive decline in Parkinson\u2019s disease. J Parkinsons Dis 5:569\u2013574. https:\/\/doi.org\/10.3233\/jpd-150583","journal-title":"J Parkinsons Dis"},{"key":"6219_CR159","doi-asserted-by":"publisher","first-page":"11719","DOI":"10.1038\/s41598-017-12086-z","volume":"7","author":"M Mishkovsky","year":"2017","unstructured":"Mishkovsky M, Anderson B, Karlsson M et al (2017) Measuring glucose cerebral metabolism in the healthy mouse using hyperpolarized 13C magnetic resonance. Sci Rep 7:11719. https:\/\/doi.org\/10.1038\/s41598-017-12086-z","journal-title":"Sci Rep"},{"key":"6219_CR160","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10334-021-00994-1","volume":"35","author":"M Kim","year":"2022","unstructured":"Kim M, Eleftheriou A, Ravotto L et al (2022) What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report. Magn Reson Mater Phy 35:87\u2013104. https:\/\/doi.org\/10.1007\/s10334-021-00994-1","journal-title":"Magn Reson Mater Phy"},{"key":"6219_CR161","doi-asserted-by":"publisher","unstructured":"Koglin N, Mueller A, Berndt M et al (2011) Specific PET imaging of xc\u2212 transporter activity using a 18F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism. Clin Cancer Res 17:6000\u20136011. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0687","DOI":"10.1158\/1078-0432.CCR-11-0687"},{"key":"6219_CR162","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41589-022-01249-3","volume":"19","author":"AN von Krusenstiern","year":"2023","unstructured":"von Krusenstiern AN, Robson RN, Qian N et al (2023) Identification of essential sites of lipid peroxidation in ferroptosis. Nat Chem Biol 19:719\u2013730. https:\/\/doi.org\/10.1038\/s41589-022-01249-3","journal-title":"Nat Chem Biol"},{"key":"6219_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108941","volume":"709","author":"C Mas-Bargues","year":"2021","unstructured":"Mas-Bargues C, Escriv\u00e1 C, Dromant M et al (2021) Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease. Arch Biochem Biophys 709:108941. https:\/\/doi.org\/10.1016\/j.abb.2021.108941","journal-title":"Arch Biochem Biophys"},{"key":"6219_CR164","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/antiox8030072","volume":"8","author":"F Ito","year":"2019","unstructured":"Ito F, Sono Y, Ito T (2019) Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants (Basel) 8:72. https:\/\/doi.org\/10.3390\/antiox8030072","journal-title":"Antioxidants (Basel)"},{"key":"6219_CR165","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/bmc.3204","volume":"28","author":"T Imazato","year":"2014","unstructured":"Imazato T, Shiokawa A, Kurose Y et al (2014) Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole. Biomed Chromatogr 28:891\u2013894. https:\/\/doi.org\/10.1002\/bmc.3204","journal-title":"Biomed Chromatogr"},{"key":"6219_CR166","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2183\/pjab.97.010","volume":"97","author":"T Miyazawa","year":"2021","unstructured":"Miyazawa T (2021) Lipid hydroperoxides in nutrition, health, and diseases. Proc Jpn Acad Ser B Phys Biol Sci 97:161\u2013196. https:\/\/doi.org\/10.2183\/pjab.97.010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"6219_CR167","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/572491","volume":"2014","author":"E Miller","year":"2014","unstructured":"Miller E, Morel A, Saso L et al (2014) Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev 2014:572491. https:\/\/doi.org\/10.1155\/2014\/572491","journal-title":"Oxid Med Cell Longev"},{"key":"6219_CR168","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jpba.2018.11.043","volume":"164","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista C, Carrascosa-Marco P, Oger C et al (2019) Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers. J PharmBiomed Anal 164:742\u2013749. https:\/\/doi.org\/10.1016\/j.jpba.2018.11.043","journal-title":"J PharmBiomed Anal"},{"key":"6219_CR169","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"key":"6219_CR170","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5483\/BMBRep.2022.55.9.109","volume":"55","author":"CTN Nguyen","year":"2022","unstructured":"Nguyen CTN, Kim SM, Kang YP (2022) Mass spectrometry-based approaches to explore metabolism regulating ferroptosis. BMB Rep 55:413\u2013416. https:\/\/doi.org\/10.5483\/BMBRep.2022.55.9.109","journal-title":"BMB Rep"},{"key":"6219_CR171","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/mds.27990","volume":"35","author":"L Chen","year":"2020","unstructured":"Chen L, Xie J (2020) Ferroptosis-suppressor-protein 1: a potential neuroprotective target for combating ferroptosis. Mov Disord 35:400. https:\/\/doi.org\/10.1002\/mds.27990","journal-title":"Mov Disord"},{"key":"6219_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18449","volume":"9","author":"Y Wu","year":"2023","unstructured":"Wu Y, Shi H, Zheng J et al (2023) Overexpression of FSP1 ameliorates ferroptosis via PI3K\/AKT\/GSK3\u03b2 pathway in PC12 cells with oxygen-glucose deprivation\/reoxygenation. Heliyon 9:e18449. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18449","journal-title":"Heliyon"},{"key":"6219_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23507","volume":"10","author":"Z Chen","year":"2024","unstructured":"Chen Z, Lin H, Wang X et al (2024) The application of approaches in detecting ferroptosis. Heliyon 10:e23507. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23507","journal-title":"Heliyon"},{"key":"6219_CR174","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.18632\/aging.205459","volume":"16","author":"S Liang","year":"2024","unstructured":"Liang S, Bai Y-M, Zhou B (2024) Identification of key ferroptosis genes and mechanisms associated with breast cancer using bioinformatics, machine learning, and experimental validation. Aging (Albany NY) 16:1781\u20131795. https:\/\/doi.org\/10.18632\/aging.205459","journal-title":"Aging (Albany NY)"},{"key":"6219_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.823741","volume":"16","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen G, Shao W (2022) Identification of ferroptosis-related genes in Alzheimer\u2019s disease based on bioinformatic analysis. Front Neurosci 16:823741. https:\/\/doi.org\/10.3389\/fnins.2022.823741","journal-title":"Front Neurosci"},{"key":"6219_CR176","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","volume":"26","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Zelic M, Han Y et al (2023) Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat Neurosci 26:12\u201326. https:\/\/doi.org\/10.1038\/s41593-022-01221-3","journal-title":"Nat Neurosci"},{"key":"6219_CR177","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY et al (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13:91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nat Chem Biol"},{"key":"6219_CR178","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.tips.2023.07.007","volume":"44","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Ugalde CL, Rolland A-S et al (2023) Therapeutic inhibition of ferroptosis in neurodegenerative disease. Trends Pharmacol Sci 44:674\u2013688. https:\/\/doi.org\/10.1016\/j.tips.2023.07.007","journal-title":"Trends Pharmacol Sci"},{"key":"6219_CR179","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2147\/JIR.S351799","volume":"15","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Lin W, Rao T et al (2022) Ferroptosis and its potential role in the nervous system diseases. J Inflamm Res 15:1555\u20131574. https:\/\/doi.org\/10.2147\/JIR.S351799","journal-title":"J Inflamm Res"},{"key":"6219_CR180","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1037","volume":"11","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Kong L, Han T et al (2023) Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer\u2019s disease molecular subtypes. Immunity Inflamm Dis 11:e1037. https:\/\/doi.org\/10.1002\/iid3.1037","journal-title":"Immunity Inflamm Dis"},{"key":"6219_CR181","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1016\/j.wneu.2024.08.070","volume":"191","author":"Q Wu","year":"2024","unstructured":"Wu Q, Liu S-P, Liu C et al (2024) Disulfidoptosis as a novel mechanism of neuronal death: insights from Creutzfeldt-Jakob disease. World Neurosurg 191:e92\u2013e106. https:\/\/doi.org\/10.1016\/j.wneu.2024.08.070","journal-title":"World Neurosurg"},{"key":"6219_CR182","doi-asserted-by":"publisher","first-page":"18939","DOI":"10.3934\/mbe.2023838","volume":"20","author":"R Qin","year":"2023","unstructured":"Qin R, Huang L, Xu W et al (2023) Identification of disulfidptosis-related genes and analysis of immune infiltration characteristics in ischemic strokes. Math Biosci Eng 20:18939\u201318959. https:\/\/doi.org\/10.3934\/mbe.2023838","journal-title":"Math Biosci Eng"},{"key":"6219_CR183","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","volume":"165","author":"RJ Bridges","year":"2012","unstructured":"Bridges RJ, Natale NR, Patel SA (2012) System xc- cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165:20\u201334. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01480.x","journal-title":"Br J Pharmacol"},{"key":"6219_CR184","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/187152710791292567","volume":"9","author":"P Albrecht","year":"2010","unstructured":"Albrecht P, Lewerenz J, Dittmer S et al (2010) Mechanisms of oxidative glutamate toxicity: the glutamate\/cystine antiporter system xc -as a neuroprotective drug target. CNS Neurol Disord DrugT argets 9:373\u2013382. https:\/\/doi.org\/10.2174\/187152710791292567","journal-title":"CNS Neurol Disord DrugT argets"},{"key":"6219_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111272","volume":"224","author":"Y Yin","year":"2025","unstructured":"Yin Y, Wang B, Yang Y et al (2025) Tectorigenin mitigates homocysteine-induced inflammation and ferroptosis in BV-2 microglial cells through promoting the SIRT1\/SLC7A11 pathway. Brain Res Bull 224:111272. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111272","journal-title":"Brain Res Bull"},{"key":"6219_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108002","volume":"99","author":"Y Gao","year":"2021","unstructured":"Gao Y, Li J, Wu Q et al (2021) Tetrahydroxy stilbene glycoside ameliorates Alzheimer\u2019s disease in APP\/PS1 mice via glutathione peroxidase related ferroptosis. Int Immunopharmacol 99:108002. https:\/\/doi.org\/10.1016\/j.intimp.2021.108002","journal-title":"Int Immunopharmacol"},{"key":"6219_CR187","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jnc.13405","volume":"136","author":"I Miyazaki","year":"2016","unstructured":"Miyazaki I, Murakami S, Torigoe N et al (2016) Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice. J Neurochem 136:194\u2013204. https:\/\/doi.org\/10.1111\/jnc.13405","journal-title":"J Neurochem"},{"key":"6219_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2024.100171","volume":"13","author":"X Liu","year":"2025","unstructured":"Liu X, Han Z, Huang Y et al (2025) HIF1\u03b1\/SLC7A11 signaling attenuates 6-hydroxydopamine-induced ferroptosis in animal and cell models of Parkinson\u2019s disease. J Neurorestoratology 13:100171. https:\/\/doi.org\/10.1016\/j.jnrt.2024.100171","journal-title":"J Neurorestoratology"},{"key":"6219_CR189","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.joim.2020.01.008","volume":"18","author":"B Lan","year":"2020","unstructured":"Lan B, Ge J-w, Cheng S-w et al (2020) Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. J Integr Med 18:344\u2013350. https:\/\/doi.org\/10.1016\/j.joim.2020.01.008","journal-title":"J Integr Med"},{"key":"6219_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118660","volume":"264","author":"X Guan","year":"2021","unstructured":"Guan X, Li Z, Zhu S et al (2021) Galangin attenuated cerebral ischemia-reperfusion injury by inhibition of ferroptosis through activating the SLC7A11\/GPX4 axis in gerbils. Life Sci 264:118660. https:\/\/doi.org\/10.1016\/j.lfs.2020.118660","journal-title":"Life Sci"},{"key":"6219_CR191","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang J, Wang Z et al (2025) Folic acid ameliorates neuronal ferroptosis in aging by up-regulating SLC7A11-GSH-GPX4 antioxidant pathway and increasing cystine levels. Int J Mol Sci 26:6669. https:\/\/doi.org\/10.3390\/ijms26146669","DOI":"10.3390\/ijms26146669"},{"key":"6219_CR192","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13287-025-04511-2","volume":"16","author":"M Zayed","year":"2025","unstructured":"Zayed M, Elwakeel E, Ezzat P et al (2025) Mesenchymal stem cell-derived exosomes as a potential therapeutic strategy for ferroptosis. Stem Cell Res Ther 16:368. https:\/\/doi.org\/10.1186\/s13287-025-04511-2","journal-title":"Stem Cell Res Ther"},{"key":"6219_CR193","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12951-024-02560-y","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu Z, Li L et al (2024) Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in ischemic stroke. J Nanobiotechnol 22:291. https:\/\/doi.org\/10.1186\/s12951-024-02560-y","journal-title":"J Nanobiotechnol"},{"key":"6219_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154762","volume":"114","author":"S Yang","year":"2023","unstructured":"Yang S, Wang L, Zeng Y et al (2023) Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2\/GPX4 axis in SAMP8 mice. Phytomedicine 114:154762. https:\/\/doi.org\/10.1016\/j.phymed.2023.154762","journal-title":"Phytomedicine"},{"key":"6219_CR195","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41531-025-00912-5","volume":"11","author":"J Xu","year":"2025","unstructured":"Xu J, He X, Li L et al (2025) Voluntary exercise alleviates neural functional deficits in Parkinson\u2019s disease mice by inhibiting microglial ferroptosis via SLC7A11\/ALOX12 axis. NPJ Park Dis 11:55. https:\/\/doi.org\/10.1038\/s41531-025-00912-5","journal-title":"NPJ Park Dis"},{"key":"6219_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154962","volume":"118","author":"X Li","year":"2023","unstructured":"Li X, Chen J, Feng W et al (2023) Berberine ameliorates iron levels and ferroptosis in the brain of 3 \u00d7 Tg-AD mice. Phytomedicine 118:154962. https:\/\/doi.org\/10.1016\/j.phymed.2023.154962","journal-title":"Phytomedicine"},{"key":"6219_CR197","doi-asserted-by":"publisher","unstructured":"Zayed M, Massoud A, Elwakeel E et al (2026) Repurposing approved drugs as ferroptosis modulators: a critical review of clinical trials in cancer and neurodegeneration. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05582-5","DOI":"10.1007\/s00210-026-05582-5"},{"key":"6219_CR198","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10495-024-01989-8","volume":"29","author":"F Xiao","year":"2024","unstructured":"Xiao F, Li H-L, Yang B et al (2024) Disulfidptosis: a new type of cell death. Apoptosis 29:1309\u20131329. https:\/\/doi.org\/10.1007\/s10495-024-01989-8","journal-title":"Apoptosis"},{"key":"6219_CR199","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nm1772","volume":"14","author":"NE Savaskan","year":"2008","unstructured":"Savaskan NE, Heckel A, Hahnen E et al (2008) Small interfering RNA\u2013mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med 14:629\u2013632. https:\/\/doi.org\/10.1038\/nm1772","journal-title":"Nat Med"},{"key":"6219_CR200","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41389-024-00535-0","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang J, Wang M, Wu S et al (2024) Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels. Oncogenesis 13:31. https:\/\/doi.org\/10.1038\/s41389-024-00535-0","journal-title":"Oncogenesis"},{"key":"6219_CR201","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuropharm.2003.08.006","volume":"46","author":"SA Patel","year":"2004","unstructured":"Patel SA, Warren BA, Rhoderick JF et al (2004) Differentiation of substrate and non-substrate inhibitors of transport system xc\u2212: an obligate exchanger of L-glutamate and L-cystine. Neuropharmacology 46:273\u2013284. https:\/\/doi.org\/10.1016\/j.neuropharm.2003.08.006","journal-title":"Neuropharmacology"},{"key":"6219_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111606","volume":"232","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang X, Wei X et al (2025) Mechanisms of metformin in alleviating neurological deficits in stroke patients: involving Ndufa11-mediated mitochondrial protection, enhanced neuronalelectrophysiology, and inhibition of disulfidptosis. Brain Res Bull 232:111606. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111606","journal-title":"Brain Res Bull"},{"key":"6219_CR203","doi-asserted-by":"publisher","first-page":"1280639","DOI":"10.3389\/fnmol.2023.1280639","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Wang J, Li Z et al (2023) Identification ferroptosis-related hub genes and diagnostic model in Alzheimer\u2019s disease. Front Mol Neurosci 16:1280639. https:\/\/doi.org\/10.3389\/fnmol.2023.1280639","journal-title":"Front Mol Neurosci"},{"key":"6219_CR204","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000289225","volume":"7","author":"D Uberti","year":"2010","unstructured":"Uberti D, Cenini G, Bonini SA et al (2010) Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. Neurodegener Dis 7:143\u2013147. https:\/\/doi.org\/10.1159\/000289225","journal-title":"Neurodegener Dis"},{"key":"6219_CR205","doi-asserted-by":"publisher","first-page":"1105690","DOI":"10.3389\/fnagi.2023.1105690","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Tang W, Xiao W et al (2023) lncRNA-associated ceRNA network revealing the potential regulatory roles of ferroptosis and immune infiltration in Alzheimer\u2019s disease. Front Aging Neurosci 15:1105690. https:\/\/doi.org\/10.3389\/fnagi.2023.1105690","journal-title":"Front Aging Neurosci"},{"key":"6219_CR206","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.humimm.2012.02.024","volume":"73","author":"JD Konowalchuk","year":"2012","unstructured":"Konowalchuk JD, Agrawal B (2012) MUC1 is a novel costimulatory molecule of human T cells and functions in an AP-1-dependent manner. Hum Immunol 73:448\u2013455. https:\/\/doi.org\/10.1016\/j.humimm.2012.02.024","journal-title":"Hum Immunol"},{"key":"6219_CR207","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/intimm\/dxh219","volume":"17","author":"B Agrawal","year":"2005","unstructured":"Agrawal B, Longenecker BM (2005) MUC1 mucin-mediated regulation of human T cells. Int Immunol 17:391\u2013399. https:\/\/doi.org\/10.1093\/intimm\/dxh219","journal-title":"Int Immunol"},{"key":"6219_CR208","doi-asserted-by":"publisher","first-page":"1364605","DOI":"10.3389\/fnagi.2024.1364605","volume":"16","author":"Y Sun","year":"2024","unstructured":"Sun Y, Xiao Y, Tang Q et al (2024) Genetic markers associated with ferroptosis in Alzheimer\u2019s disease. Front Aging Neurosci 16:1364605. https:\/\/doi.org\/10.3389\/fnagi.2024.1364605","journal-title":"Front Aging Neurosci"},{"key":"6219_CR209","doi-asserted-by":"publisher","first-page":"1023947","DOI":"10.3389\/fncel.2022.1023947","volume":"16","author":"B Wang","year":"2022","unstructured":"Wang B, Fu C, Wei Y et al (2022) Ferroptosis-related biomarkers for Alzheimer\u2019s disease: identification by bioinformatic analysis in hippocampus. Front Cell Neurosci 16:1023947. https:\/\/doi.org\/10.3389\/fncel.2022.1023947","journal-title":"Front Cell Neurosci"},{"key":"6219_CR210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.09.025","volume":"587","author":"W Bao","year":"2025","unstructured":"Bao W, Ge Y, Huang J et al (2025) DJ-1\/PARK7 in Parkinson\u2019s disease: mechanisms of pathogenesis and therapeutic potential. Neuroscience 587:1\u201313. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.09.025","journal-title":"Neuroscience"},{"key":"6219_CR211","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnagi.2019.00372","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K et al (2020) Emerging role of sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci 11:372. https:\/\/doi.org\/10.3389\/fnagi.2019.00372","journal-title":"Front Aging Neurosci"},{"key":"6219_CR212","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1021\/acschemneuro.7b00287","volume":"8","author":"WJ Geldenhuys","year":"2017","unstructured":"Geldenhuys WJ, Benkovic SA, Lin L et al (2017) MitoNEET (CISD1) knockout mice show signs of striatal mitochondrial dysfunction and a Parkinson\u2019s disease phenotype. ACS Chem Neurosci 8:2759\u20132765. https:\/\/doi.org\/10.1021\/acschemneuro.7b00287","journal-title":"ACS Chem Neurosci"},{"key":"6219_CR213","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41467-021-20904-2","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Song X, Kuang F et al (2021) NUPR1 is a critical repressor of ferroptosis. Nat Commun 12:647. https:\/\/doi.org\/10.1038\/s41467-021-20904-2","journal-title":"Nat Commun"},{"key":"6219_CR214","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41531-024-00776-1","volume":"10","author":"T Suzuki","year":"2024","unstructured":"Suzuki T, Bono H (2024) A systematic exploration of unexploited genes for oxidative stress in Parkinson\u2019s disease. NPJ Park Dis 10:160. https:\/\/doi.org\/10.1038\/s41531-024-00776-1","journal-title":"NPJ Park Dis"},{"key":"6219_CR215","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.bbi.2020.04.007","volume":"88","author":"CA Aguirre","year":"2020","unstructured":"Aguirre CA, Morale MC, Peng Q et al (2020) Two single nucleotide polymorphisms in IL13 and IL13RA1 from individuals with idiopathic Parkinson\u2019s disease increase cellular susceptibility to oxidative stress. Brain Behav Immun 88:920\u2013924. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.007","journal-title":"Brain Behav Immun"},{"key":"6219_CR216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295699","volume":"18","author":"L Chen","year":"2023","unstructured":"Chen L, Xin G, He Y et al (2023) Study of molecular patterns associated with ferroptosis in Parkinson\u2019s disease and its immune signature. PLoS ONE 18:e0295699. https:\/\/doi.org\/10.1371\/journal.pone.0295699","journal-title":"PLoS ONE"},{"key":"6219_CR217","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.biochem.72.121801.161647","volume":"74","author":"JS Valentine","year":"2005","unstructured":"Valentine JS, Doucette PA, Zittin PS (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563\u2013593. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161647","journal-title":"Annu Rev Biochem"},{"key":"6219_CR218","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1007\/s10528-024-10832-3","volume":"63","author":"Y Yang","year":"2025","unstructured":"Yang Y, Bai Q, Liu F et al (2025) Establishment of the diagnostic signature of ferroptosis genes in Multiple Sclerosis. Biochem Genet 63:3065\u20133094. https:\/\/doi.org\/10.1007\/s10528-024-10832-3","journal-title":"Biochem Genet"},{"key":"6219_CR219","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000031802","volume":"101","author":"S-C Gu","year":"2022","unstructured":"Gu S-C, Yuan C-X, Gu C (2022) Identification of ferroptosis-related gene signatures associated with multiple sclerosis using weighted gene co-expression network analysis. Medicine (Baltimore) 101:e31802. https:\/\/doi.org\/10.1097\/md.0000000000031802","journal-title":"Medicine (Baltimore)"},{"key":"6219_CR220","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3390\/ijms25053016","volume":"25","author":"L Stojkovic","year":"2024","unstructured":"Stojkovic L, Jovanovic I, Dincic E et al (2024) Targeted RNAseq revealed the gene expression signature of ferroptosis-related processes associated with disease severity in patients with MultipleSclerosis. Int J Mol Sci 25:3016. https:\/\/doi.org\/10.3390\/ijms25053016","journal-title":"Int J Mol Sci"},{"key":"6219_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2025.100207","volume":"18","author":"MH Jamal","year":"2025","unstructured":"Jamal MH, Dhupar M, Aran KR (2025) Exploring the role of ferroptosis pathways in Huntington\u2019s disease: insight of pathophysiology to emerging treatment. Brain Disord 18:100207. https:\/\/doi.org\/10.1016\/j.dscb.2025.100207","journal-title":"Brain Disord"},{"key":"6219_CR222","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuro.2018.10.012","volume":"70","author":"GF Kwakye","year":"2019","unstructured":"Kwakye GF, Jim\u00e9nez JA, Thomas MG et al (2019) Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms. Neurotoxicology 70:48\u201361. https:\/\/doi.org\/10.1016\/j.neuro.2018.10.012","journal-title":"Neurotoxicology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06219-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06219-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06219-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:03:16Z","timestamp":1790186596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06219-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":222,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6219"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06219-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"916"}}